Metric Finance
LearnFAQ
LearnFAQ

Learn / VRTX

NASDAQ: VRTX

Vertex Pharmaceuticals Inc / Ma (VRTX) stock, explained like you're 5

Vertex Pharmaceuticals Inc / Ma trades on the Nasdaq under the ticker VRTX. It is a large cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 129.3 billion dollars.

Ticker
VRTX
Exchange
Nasdaq
Sector
Healthcare
Industry
Pharmaceutical Preparations
Size
Large cap, about 129.3 billion dollars

Is Vertex Pharmaceuticals Inc / Ma a small, medium or large cap company?

Yes. Vertex Pharmaceuticals Inc / Ma is a large cap stock. Its market cap, which is the total value of all its shares, is about 129.3 billion dollars.

Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.

How Vertex Pharmaceuticals Inc / Ma makes money

  • Selling medicines, medical devices or healthcare services.
  • Insurance premiums or hospital and clinic fees.
  • Research and licensing deals.

What moves VRTX stock

  • Results from clinical trials and approvals from regulators.
  • Drug prices, insurance rules and government policy.
  • Patents running out and new competing treatments.

In the news lately

  • What Vertex Pharmaceuticals (VRTX)'s Pancreas Recovery Data Means For Shareholders (Yahoo Finance)
  • Vertex Pharmaceuticals (VRTX) Stock Forecast and Price Target 2026 $VRTX (MarketBeat)
  • Vertex Pharmaceuticals (NasdaqGS:VRTX) Stock Forecast & Analyst Predictions (Simply Wall Street)
  • Why Vertex Pharmaceuticals (VRTX) Stock Is Down Today (Quiver Quantitative)
  • Vertex (VRTX) Stock May Be 35% Undervalued Despite New ALYFTREK Data (Yahoo Finance)

Follow VRTX in your daily brief

Each trading day at 5 PM ET we post what happened to Vertex Pharmaceuticals Inc / Ma and why it matters, in simple words. Free.

Start my free brief

Key terms to know before you follow VRTX

  • Market cap
  • P/E ratio
  • EPS (earnings per share)
  • Earnings report
  • Volatility

Questions about Vertex Pharmaceuticals Inc / Ma stock

What does Vertex Pharmaceuticals Inc / Ma do?

Vertex Pharmaceuticals Inc / Ma trades on the Nasdaq under the ticker VRTX. It is a large cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 129.3 billion dollars.

What is the ticker symbol for Vertex Pharmaceuticals Inc / Ma?

Vertex Pharmaceuticals Inc / Ma trades under the ticker VRTX on the Nasdaq.

What is Vertex Pharmaceuticals Inc / Ma's market cap?

Vertex Pharmaceuticals Inc / Ma is a large cap stock with a market cap of about 129.3 billion dollars.

How does Vertex Pharmaceuticals Inc / Ma make money?

Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.

What moves VRTX stock?

Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.

How can I follow VRTX stock every day?

Add VRTX to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.

Follow VRTX daily

A free brief on Vertex Pharmaceuticals Inc / Ma and your other stocks, every trading day at 5 PM ET.

Start my free brief

Similar stocks

  • NVS · Novartis AG
  • AZN · Astrazeneca PLC
  • NVO · Novo Nordisk A S
  • SNY · Sanofi

Similar stocks

  • NVSNovartis AG
  • AZNAstrazeneca PLC
  • NVONovo Nordisk A S
  • SNYSanofi

Compare VRTX: VRTX vs NVS, VRTX vs AZN, VRTX vs NVO

Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.

Metric Finance

Stocks explained like you're 5.

Product

  • Learn
  • FAQ
  • Your account

Legal

  • Privacy
  • Terms

Support

  • Contact
  • Unsubscribe

© 2026 Metric Finance

Built by Yashna & Vansh · Not investment advice · Market data may be delayed